Indeed, GR expression has different prognostic values depending on the BC subtypes, with a high expression of GR being correlated with a worse prognosis in TNBC and with a better prognosis in early-stage ERα-positive BCs [11,96,97]. The gene discussed is NR3C1; the disease is breast cancer.